tiprankstipranks
Aptorum Group Ltd (APM)
NASDAQ:APM
Holding APM?
Track your performance easily

Aptorum Group (APM) Stock Price & Analysis

154 Followers

APM Stock Chart & Stats


Financials

Annual

Ownership Overview

0.08%0.48%98.17%
Insiders
0.48% Other Institutional Investors
98.17% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

APM FAQ

What was Aptorum Group Ltd’s price range in the past 12 months?
Aptorum Group Ltd lowest stock price was $0.46 and its highest was $17.49 in the past 12 months.
    What is Aptorum Group Ltd’s market cap?
    Currently, no data Available
    When is Aptorum Group Ltd’s upcoming earnings report date?
    Aptorum Group Ltd’s upcoming earnings report date is Apr 21, 2025 which is in 150 days.
      How were Aptorum Group Ltd’s earnings last quarter?
      Currently, no data Available
      Is Aptorum Group Ltd overvalued?
      According to Wall Street analysts Aptorum Group Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Aptorum Group Ltd pay dividends?
        Aptorum Group Ltd does not currently pay dividends.
        What is Aptorum Group Ltd’s EPS estimate?
        Aptorum Group Ltd’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Aptorum Group Ltd have?
        Aptorum Group Ltd has 2,937,921 shares outstanding.
          What happened to Aptorum Group Ltd’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Aptorum Group Ltd?
          Currently, no hedge funds are holding shares in APM
          ---

          Company Description

          Aptorum Group Ltd

          Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Soligenix
          Oncternal Therapeutics
          Microbot Medical
          Armata Pharmaceuticals
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis